United States · FDA National Drug Code directory
CETIRIZINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-357_36fee17d-2444-41d2-aca7-2f22d3f87cc0
- Product NDC
- 57237-357
- Form
- SOLUTION
- Composition / generic term
- CETIRIZINE HYDROCHLORIDE
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251111
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE, PLASTIC (57237-357-12) · 57237-357-12
- 240 mL in 1 BOTTLE, PLASTIC (57237-357-24) · 57237-357-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →